Matches in DBpedia 2014 for { ?s ?p Chad A. Mirkin (born November 23, 1963) is an American chemist. He is the George B. Rathmann Professor of Chemistry, Professor of Medicine, Professor of Materials Science and Engineering, Professor of Biomedical Engineering, and Professor of Chemical and Biological Engineering, and Director of the International Institute for Nanotechnology and Center for Nanofabrication and Molecular Self-Assembly at Northwestern University. He received his B.S. degree from Dickinson College in 1986 and his Ph.D. from Penn State University in 1989.Mirkin is known for his development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography (recently recognized by National Geographic as one of the top 100 scientific discoveries that changed the world), and contributions to supramolecular chemistry, nanoelectronics, and nanooptics. In 2010, he was listed as the most cited chemist in the world over the last decade in terms of total citations, the second highest most cited chemist in terms of impact factor, and the top most cited nanomedicine researcher. He is one of only fifteen scientists, engineers and medical doctors, and the only chemist to be elected into all three branches of the National Academies. He has published over 560 manuscripts (H-index =115) and has over 900 patents and patent applications (246 issued, over 90% licensed as of January 1, 2014). These discoveries and innovations have led to over 1400 commercial products that are being sold world-wide.The focus of his research is on developing methods for controlling the architecture of molecules and materials on the 1 - 100 nm length scale and utilizing such structures in the development of analytical tools that can be used in the areas of chemical and biological sensing, lithography, catalysis, and optics. Mirkin has pioneered the use of biomolecules as synthons in materials science and the development of nanoparticle-based biodiagnostics. A common strategy used by Mirkin's group is the use of the unique properties of Spherical Nucleic Acids (SNAs, spherical arrangements of nucleic acids with or without organic or inorganic nanoparticle core) to enable the synthesis of novel materials and colloidal crystals, the development of high sensitivity probes for chemical and medical diagnostic purposes, and single-entity structures capable of intracellular gene regulation. His 1996 work with SNA-gold nanoparticle conjugates introduced the concept of a nanoparticle as an atom and nucleic acids as bonds, and it laid the ground work for the modern field of molecular diagnostics based upon well-defined nanoparticle and nanocrystal bioconjugates. His genomic assays are the cornerstone of Nanosphere Inc.'s FDA-cleared Verigene system and EMD Millipore's SmartFlare platform.On April 27, 2009, it was announced that Mirkin was appointed to President Barack Obama's President's Council of Advisors on Science and Technology.Mirkin has served on over Editorial Advisory Boards, including the Journal of the American Chemical Society and Angewandte Chemie. He is the Founding Editor of the journal Small, one of the premier international nanotechnology journals, and he is an Associate Editor of the Journal of the American Chemical Society. Mirkin is a founder of multiple companies, including Nanosphere,Nanoink, AuraSense, and AuraSense Therapeutics.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Chad_Mirkin abstract "Chad A. Mirkin (born November 23, 1963) is an American chemist. He is the George B. Rathmann Professor of Chemistry, Professor of Medicine, Professor of Materials Science and Engineering, Professor of Biomedical Engineering, and Professor of Chemical and Biological Engineering, and Director of the International Institute for Nanotechnology and Center for Nanofabrication and Molecular Self-Assembly at Northwestern University. He received his B.S. degree from Dickinson College in 1986 and his Ph.D. from Penn State University in 1989.Mirkin is known for his development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography (recently recognized by National Geographic as one of the top 100 scientific discoveries that changed the world), and contributions to supramolecular chemistry, nanoelectronics, and nanooptics. In 2010, he was listed as the most cited chemist in the world over the last decade in terms of total citations, the second highest most cited chemist in terms of impact factor, and the top most cited nanomedicine researcher. He is one of only fifteen scientists, engineers and medical doctors, and the only chemist to be elected into all three branches of the National Academies. He has published over 560 manuscripts (H-index =115) and has over 900 patents and patent applications (246 issued, over 90% licensed as of January 1, 2014). These discoveries and innovations have led to over 1400 commercial products that are being sold world-wide.The focus of his research is on developing methods for controlling the architecture of molecules and materials on the 1 - 100 nm length scale and utilizing such structures in the development of analytical tools that can be used in the areas of chemical and biological sensing, lithography, catalysis, and optics. Mirkin has pioneered the use of biomolecules as synthons in materials science and the development of nanoparticle-based biodiagnostics. A common strategy used by Mirkin's group is the use of the unique properties of Spherical Nucleic Acids (SNAs, spherical arrangements of nucleic acids with or without organic or inorganic nanoparticle core) to enable the synthesis of novel materials and colloidal crystals, the development of high sensitivity probes for chemical and medical diagnostic purposes, and single-entity structures capable of intracellular gene regulation. His 1996 work with SNA-gold nanoparticle conjugates introduced the concept of a nanoparticle as an atom and nucleic acids as bonds, and it laid the ground work for the modern field of molecular diagnostics based upon well-defined nanoparticle and nanocrystal bioconjugates. His genomic assays are the cornerstone of Nanosphere Inc.'s FDA-cleared Verigene system and EMD Millipore's SmartFlare platform.On April 27, 2009, it was announced that Mirkin was appointed to President Barack Obama's President's Council of Advisors on Science and Technology.Mirkin has served on over Editorial Advisory Boards, including the Journal of the American Chemical Society and Angewandte Chemie. He is the Founding Editor of the journal Small, one of the premier international nanotechnology journals, and he is an Associate Editor of the Journal of the American Chemical Society. Mirkin is a founder of multiple companies, including Nanosphere,Nanoink, AuraSense, and AuraSense Therapeutics.".